Aortic diseases like aneurysms and dissections have long been among the most complex challenges in cardiovascular care. High surgical risks and late diagnoses have made timely treatment difficult, often with life-threatening consequences.

In India alone, it is estimated that over 600,000 people are affected by aortic conditions every year. Many are diagnosed too late; others are never diagnosed at all. These numbers reflect not just a medical challenge, but a critical need for earlier detection and more accessible care.

That, however, is beginning to change. The aorta is now at the centre of some of the most important advancements in cardiovascular care. These developments are enabling earlier diagnosis, expanding access to treatment, and significantly improving outcomes for patients who need timely intervention the most.

With decades of experience at the intersection of innovation and patient-centric care, we have witnessed a remarkable transformation in the way aortic disease is approached. Today, surgical solutions like hybrid repairs and custom grafts are turning high-risk, high-mortality cases into powerful stories of recovery and resilience.

Striking the Right Balance in Care

While open surgery has long been the gold standard for treating aortic disease, it’s not always viable, particularly for elderly patients or those with multiple comorbidities.

In complex cases like aortic dissections, hybrid procedures offer a life-saving alternative. These surgeries blend the precision of minimally invasive techniques with the control of open repair, all in a single, well-orchestrated procedure. Performed in state-of-the-art hybrid ORs, they allow surgical teams to adapt in real time to the patient’s anatomy and risk level.

The clinical outcomes are promising. Hybrid arch repairs are demonstrating lower perioperative mortality and fewer complications compared to traditional approaches, especially in patients deemed unfit for open surgery. For hospitals, these procedures also enable faster ICU turnovers, shorter inpatient stays, and reduced radiological interventions, a win-win for both patients and care teams.

Why Customisation Matters

One of the most exciting advancements in this space is the rise of custom stents and surgical grafts. Unlike off-the-shelf devices, custom grafts are tailored to a patient’s unique vascular anatomy, especially valuable in tortuous or angulated aortic arches, where poor fits can lead to complications or graft migration.

A 2024 review published in the Journal of Vascular Surgery found that patient-specific endografts reduced the need for reintervention by up to 30% in complex thoracoabdominal cases. That’s not just a statistic; it’s time, money, and quality of life preserved, especially when a second surgery might not be an option.

Recovery That Reflects Real Progress

As an industry, our success isn’t measured only by survival rates. It’s also about how quickly a patient can return home, resume daily life, and heal with dignity.

Hybrid techniques are helping make that a reality, consistently leading to shorter ICU stays (often 40–50% less) and faster recoveries. This progress is making a real difference, not just for families, but for hospitals balancing increasing patient volumes with limited resources.

Technology is accelerating this shift. AI and advanced imaging are reshaping pre-operative planning, moving us from a reactive approach to a predictive one. Machine learning is already enabling surgical teams to simulate outcomes based on a patient’s profile, comorbidities, and graft type, leading to more precise planning, fewer surprises in the OR, and faster, more confident decision-making.

Bridging the Awareness Gap

Despite these advancements, one thing hasn’t kept pace: public awareness. Aortic diseases still fly under the radar. Symptoms like persistent back pain or chest pressure are often mistaken for routine fatigue. Many patients reach specialised care only when the condition has progressed beyond early intervention.

This needs to change. A national push for early screening, especially for smokers, those over 60, or individuals with a family history, is essential. Primary care physicians and cardiologists play a pivotal role in identifying risk early, but patient education is equally critical.

Also read: Why Healthcare Is the New Frontline for Cybercrime, and How to Defend It

Final Thoughts

What excites me most about the future of cardiovascular care is not just the ability to treat disease, but the ability to expand access, improve recovery, and redefine what’s possible for patients who need it the most.

Real change in healthcare doesn’t come from a singular breakthrough. It comes from consistent commitment to better tools, smarter planning, and, above all, to better outcomes for every patient.

We’re no longer asking, “Can we treat this?”
We’re asking, “How can we treat this better?”

And that mindset makes all the difference.

Views expressed by: Dharampal Singh Rawat, Senior Director of Cardiovascular (CV), Terumo Aortic (TA), and Life Care Solutions (LCS) at Terumo India

Like

Dislike

Be a part of Elets Collaborative Initiatives. Join Us for Upcoming Events and explore business opportunities. Like us on Facebook , connect with us on LinkedIn and follow us on Twitter , Instagram.

Disclaimer: The views and opinions expressed in this article are solely those of the author and do not necessarily reflect the official policy or views of any organisation. The content is intended for informational and educational purposes only and should not be construed as medical advice.

"Exciting news! Elets technomedia is now on WhatsApp Channels Subscribe today by clicking the link and stay updated with the latest insights!" Click here!